We innovate to create.
Zymeron is a research-based biotechnology company that discover, develop and commercialize innovative technologies.
Zymeron operates as an innovation engine to advance technologies in medical diagnostics and therapeutics, and bioinspired synthetic materials.
Infectious Disease Control
Discover and advance revolutionary precision medicine technologies to prevent and treat infectious diseases and immunological disorders.
Develop game-changing medical countermeasures to detect, prevent and mitigate adverse health effects imposed by chemical, radiation and emerging threats.
Point of Care Tests (POCT)
Empowered by interdisciplinary innovations, develop rapid diagnostic tests and assays for end users in the field, clinical offices and hospital bedsides.
Innovate to create advanced materials and material systems using bioinspired synthetic methods and engineering strategies to deliver a step-change in performance.
Our capabilities statement is organized as success stories in each of our technology focus areas, including rapid reduction of concept to practice, feasibility demonstration, prototyping and pilot production, human factors and usability engineering, design controls to ensure safe and effective products, and our commitment to excellence.
We have an extended list of partners in academia, industry, government, and non-profit organizations. We work closely with numerous government agencies including the Department of Defense and the Department of Health and Human Services to develop innovative products to meet the nation’s health and defense needs. We commercialize advanced materials and health-related technologies and bring them to market in partnership with commercial entities.